| 产品: | SLFN14 抗体 |
| 货号: | DF13579 |
| 描述: | Rabbit polyclonal antibody to SLFN14 |
| 应用: | WB |
| 文献验证: | WB |
| 反应: | Human |
| 预测: | Horse, Rabbit |
| 蛋白号: | P0C7P3 |
| RRID: | AB_2846598 |
产品描述
来源:
Rabbit
应用:
WB 1:500-1:2000
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
反应:
Human
克隆:
Polyclonal
特异性:
SLFN14 Antibody detects endogenous levels of total SLFN14.
RRID:
AB_2846598
引用格式: Affinity Biosciences Cat# DF13579, RRID:AB_2846598.
引用格式: Affinity Biosciences Cat# DF13579, RRID:AB_2846598.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:
展开/折叠
Schlafen family member 14; SLFN14; SLN14_HUMAN;
抗原和靶标
免疫原:
A synthesized peptide derived from human SLFN14, corresponding to a region within C-terminal amino acids.
基因/基因ID:
文献引用
1). Novel mutation SLFN14 T853fs associated with inherited macrothrombocytopenia. Molecular therapy. Nucleic acids, 2025
(PubMed: 40510593)
[IF=6.5]
Application: WB Species: human Sample:
Figure 3 T853fs leads to low expression level of SLFN14 (A and B) HEK293T and Meg-01 cells were transfected with SLFN14-WT or SLFN14-T853fs overexpression plasmids for 48 h. The expressions of exogenous SLFN14 were determined by (A) real time qPCR and (B) western blot. Both representative figures and quantification data for western blot are shown. GAPDH was used as an internal reference. (C) Western blot analysis of SLFN14 protein expression in platelet lysates of the proband and two healthy subjects (control 1 and control 2). Both representative figures and quantification data are shown. (D) rRNA degradation in SLFN14-WT and SLFN14-T853fs) overexpressing HEK293T cells was assessed by denaturing agarose/formaldehyde gel electrophoresis (n = 3 independent experiments). (E) Cell proliferation of MEG-01 cells that were transfected by empty vector (EV), SLFN14-WT, or SLFN14-T853fs overexpression plasmids was determined by Cell Counting Kit-8 (CCK-8) assay. (F) Immunofluorescence staining against SLFN14 (red) of MEG-01 cells transfected with SLFN14-WT or SLFN14-T853fs overexpression plasmids for 48 h. Nuclei were counterstained with DAPI (blue). Merged images indicate the overlay of SLFN14 and nuclei signals. Images were captured using a 60× objective. Scale bars: 20 μm. Data are presented as mean ± standard deviation (SD). Comparisons between two groups were conducted using unpaired two-tailed Student’s t test.
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.